The Fourth International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy (http://www.cancermets.org)—May 12-14, 2011 at the InterContinental New York Barclay Hotel in New York City—will offer an extensive CME-program detailing the latest discoveries about the mechanisms of cancer metastasis and updating cutting-edge results from clinical trials. Biomarkers and their diagnostic and prognostic applications in metastatic cancer and their usefulness in molecular targeted therapy are a major focus, according to Symposium chairman Stanley P.L. Leong, MD, FACS, president of the Sentinel Node Oncology Foundation and chief of Cutaneous Oncology, and associate director of the Melanoma Program at California Pacific Medical Center, in San Francisco.
Sponsored by the National Cancer Institute (NCI), the Arizona Cancer Center, the Sentinel Node Oncology Foundation, AiM at Melanoma, and Sutter Pacific Medical Foundation, the Fourth International Symposium on Cancer Metastasis is designed to meet the educational needs of physicians and researchers involved in all oncology disciplines and subspecialties, including medical, surgical, and radiation oncologists; pathologists; and other translational-oriented laboratory scientists. Highlights include four mini-symposia: (1) New Paradigms of Cancer Treatment Based on Recent Results from the Sentinel Lymph Node Trials, including Armando Giuliano, MD, FACS; Monica Morrow, MD, FACS; and Donald Morton, MD, FACS; (2) Breast Cancer Update 2011, including Hope Rugo, MD; William Gradishar, MD; and Clifford Hudis, MD.; (3) Progression of Metastatic Melanoma: Implications for Treatment, including John Kirkwood, MD; Steven O’Day, MD; Dave Hoon, PhD; and Alexander Eggermont, MD, PhD; and 4) Meeting the Biologic Challenge of Colorectal Metastases, including Phillip Paty, MD; Nancy Kemeny, MD; and Michael D’Angelica, MD). The program includes cash awards for the five best metastasis-related abstracts submitted by young Investigators (under age 40) and Trainees (residents, fellows, or students). Authors of the three best abstracts submitted by General Attendees (investigators over 40, physicians who are not residents or fellows) will present their work. but with no cash award. To register or for more information, visit http://www.cancermets.org or call Paradigm Medical Communications, the Symposium’s ACCME-accredited CME-provider, at 845-398-5100, ext. 20.